Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.560
-0.030 (-1.16%)
At close: Oct 2, 2026, 4:00 PM EDT
2.610
+0.050 (1.95%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $281.02 million as of October 2, 2026. Its market cap has decreased by -17.59% in one year.
Market Cap
281.02M
Enterprise Value
22.07M
1-Year Change
-17.59%
Ranking
Category
Stock Price
$2.56
ChartMarket Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $281.02M, an increase of 194.88%. That is a compound annual growth rate of 9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 281.02M | -26.03% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 291.53M |
| Vanda Pharmaceuticals | 290.83M |
| Clinuvel Pharmaceuticals | 287.99M |
| Abeona Therapeutics | 286.49M |
| Indaptus Therapeutics | 282.47M |
| X4 Pharmaceuticals | 280.59M |
| Fulcrum Therapeutics | 280.01M |
| AC Immune | 279.39M |